Schwab M - Search Results

1

Inhibition of human CYP2B6 by N,N',N''-triethylenethiophosphoramide is irreversible and mechanism-based.

Richter T, Schwab M, Eichelbaum M, Zanger UM. Richter T, et al. Among authors: schwab m. Biochem Pharmacol. 2005 Feb 1;69(3):517-24. doi: 10.1016/j.bcp.2004.10.008. Epub 2004 Dec 15. Biochem Pharmacol. 2005. PMID: 15652242

2

Atrial fibrillation after coronary artery bypass surgery: association with changes in G protein levels in mononuclear leukocytes.

Tittelbach V, Schwab M, Volff JN, Mörike K, Lemke P, Giray J, Lee P, Ratge D, Hellberg K, Wisser H. Tittelbach V, et al. Among authors: schwab m. Naunyn Schmiedebergs Arch Pharmacol. 1999 Mar;359(3):204-11. doi: 10.1007/pl00005343. Naunyn Schmiedebergs Arch Pharmacol. 1999. PMID: 10208307

3

Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs.

Kreth K, Kovar K, Schwab M, Zanger UM. Kreth K, et al. Among authors: schwab m. Biochem Pharmacol. 2000 Jun 15;59(12):1563-71. doi: 10.1016/s0006-2952(00)00284-7. Biochem Pharmacol. 2000. PMID: 10799653

4

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.

Lang T, Klein K, Fischer J, Nüssler AK, Neuhaus P, Hofmann U, Eichelbaum M, Schwab M, Zanger UM. Lang T, et al. Among authors: schwab m. Pharmacogenetics. 2001 Jul;11(5):399-415. doi: 10.1097/00008571-200107000-00004. Pharmacogenetics. 2001. PMID: 11470993

5

Pharmacokinetic considerations in the treatment of inflammatory bowel disease.

Schwab M, Klotz U. Schwab M, et al. Clin Pharmacokinet. 2001;40(10):723-51. doi: 10.2165/00003088-200140100-00003. Clin Pharmacokinet. 2001. PMID: 11707060 Review.

6

Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism.

Lutz M, Schwab M, Griese EU, Marx C, Müller-Oerlinghausen B, Schönhöfer PS, Meisner C, Gleiter CH, Eichelbaum M, Mörike K. Lutz M, et al. Among authors: schwab m. Pharmacogenetics. 2002 Jan;12(1):73-5. doi: 10.1097/00008571-200201000-00010. Pharmacogenetics. 2002. PMID: 11773867

7

MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.

Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U, Eichelbaum M, Fromm MF. Drescher S, et al. Among authors: schwab m. Br J Clin Pharmacol. 2002 May;53(5):526-34. doi: 10.1046/j.1365-2125.2002.01591.x. Br J Clin Pharmacol. 2002. PMID: 11994059 Free PMC article. Clinical Trial.

8

Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation.

Bredschneider M, Klein K, Mürdter TE, Marx C, Eichelbaum M, Nüssler AK, Neuhaus P, Zanger UM, Schwab M. Bredschneider M, et al. Among authors: schwab m. Clin Pharmacol Ther. 2002 Jun;71(6):479-87. doi: 10.1067/mcp.2002.124518. Clin Pharmacol Ther. 2002. PMID: 12087351

9

Genetic polymorphisms of the human MDR1 drug transporter.

Schwab M, Eichelbaum M, Fromm MF. Schwab M, et al. Annu Rev Pharmacol Toxicol. 2003;43:285-307. doi: 10.1146/annurev.pharmtox.43.100901.140233. Epub 2002 Jan 10. Annu Rev Pharmacol Toxicol. 2003. PMID: 12359865 Review.

10

6-thioguanine--efficacy and safety in chronic active Crohn's disease.

Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Deibert P, Fellermann K, Greinwald R, Stange EF. Herrlinger KR, et al. Among authors: schwab m. Aliment Pharmacol Ther. 2003 Feb 15;17(4):503-8. doi: 10.1046/j.1365-2036.2003.01440.x. Aliment Pharmacol Ther. 2003. PMID: 12622758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results